According to Adicet Bio's latest financial reports the company has a price-to-book ratio of 0.8088.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.4794 | -63.42% |
2022-12-31 | 1.31 | -41.98% |
2021-12-31 | 2.26 | -10.28% |
2020-12-31 | 2.52 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Novartis NVS | 4.25 | 425.83% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.61 | 99.09% | ๐บ๐ธ USA |
Merck MRK | 8.83 | 991.74% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1.92 | 138.00% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | 4.03 | 398.30% | ๐บ๐ธ USA |
Quaker Houghton KWR | 2.47 | 205.30% | ๐บ๐ธ USA |